N-[2-chloro-5-(trifluoromethyl)phenyl]-2-iodoacetamide(17641-01-9)
- Name: N-[2-chloro-5-(trifluoromethyl)phenyl]-2-iodoacetamide
- Synonyms:
- Molecular Formula:C9H6ClF3INO
- Molecular Weight:363.5027
- CAS Registry Number:17641-01-9
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.17641-01-9 N-[2-chloro-5-(trifluoromethyl)phenyl]-2-iodo-acetamide
Assay:90%,98% Appearance:detailed see specifications Package:according to the clients requirement Storage:Store in dry, dark and ventilated place. Transportation:by air or by sea Application:Used in Synthesis, Pharmaceuticals and other fields
Min. Order:1Kilogram
Supplier:Dayang Chem (Hangzhou) Co.,Ltd. [
China (Mainland)]
CAS No.17641-01-9 17641-01-9
Assay:99% Appearance:White powder Package:25KGS/Drum Storage:Room temperature Transportation:BY SEA Application:API锛孭harmaceutical intermediates
Min. Order:1Gram
Supplier:HENAN NEW BLUE CHEMICAL CO.,LTD [
China (Mainland)]
CAS No.17641-01-9 N-[2-chloro-5-(trifluoromethyl)phenyl]-2-iodo-acetamide
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]
CAS No.17641-01-9 N-[2-chloro-5-(trifluoromethyl)phenyl]-2-iodo-acetamide
Assay:99% Application:Fine chemical intermediates, used as the main raw material for the synthesis of various pesticides, medicines, surfactants, polymer monomers, and antifungal agents
Min. Order:0
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)]
CAS No.17641-01-9 N-[2-chloro-5-(trifluoromethyl)phenyl]-2-iodoacetamide
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:N-[2-chloro-5-(trifluoromethyl)phenyl]-2-iodoacetamide
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]

Other Product
- 28805-80-3/Carbamic acid,N-(3-isocyanatomethylphenyl)-,C,C'-[2-ethyl-2-[[[[(3-isocyanatomethylphenyl)amino]carbonyl]oxy]methyl]-1,3-propanediyl]ester
- 143323-55-1/L 012
- 7027-11-4/5-oxo-1,3,3-trimethyl-cyclohexanecarbonitril
- 32503-00-7/1-[4-({(1E)-[2-(4-chlorophenyl)hydrazino]methylidene}amino)phenyl]-3-(2-methylpropyl)thiourea hydrochloride
- 74012-72-9/Platinum(2+), (N-(2-aminoethyl)-1,2-ethanediamine-N,N,N)(6,9-dihydro-7,9-dimethyl-6-oxo-1H-puriniumato-N(1))-, (SP-4-2)-, bis(hexafluorophosphate(1-))
- 28321-33-7/α-Isopropyl-α-(2-piperidinoethyl)-1-naphthaleneacetaldehyde
- 57897-24-2/6,7,8-Trimethoxy-2,3a,4,5-tetrahydro-3H-benzo[g]indazol-3-one
- 18181-26-5/({[3,5-bis(trifluoromethyl)phenyl](ethyl)amino}methylidene)propanedinitrile
- 56495-82-0/IRISQUINONE
- 170080-02-1/2(5H)-Furanone,3-[15-hydroxy-15-[tetrahydro-5-(1-hydroxytridecyl)-2-furanyl]pentadecyl]-5-methyl-(9CI)
- 94134-93-7/[4-(1-methylethyl)phenyl]methyl salicylate
- 20640-71-5/2-[(4-amino-9,10-dihydro-9,10-dioxo-3-sulfo-1-anthracenyl) amino]-4-[[2-(sulfooxy)ethyl]sulfonyl]-Benzoic acid
- 50-35-1/Thalidomide
- 496-83-3/2-hydroxycyclononanone
- 126-75-0/DEMETON S
- 25655-83-8/Dihydrol
- 6221-96-1/hexadecyl propionate
- 17641-01-9/N-[2-chloro-5-(trifluoromethyl)phenyl]-2-iodoacetamide
- 13393-61-8/dibutylhydroxylamine
- 1846-74-8/3-Benzoylcoumarin
- 142457-04-3/3,4-EPOXY-5-HYDROXY-5-ISOPROPYL-3-(METHOXYCARBONYL)-4-METHYL-GAMMA-BUTYROLACTAM
- 62-67-9/NALORPHINE
- 24932-78-3/6-[4-(2-methoxyphenyl)piperazin-1-yl]-7H-purine methanesulfonate (1:2)
- 85850-00-6/Methanamine,1-[3-methoxy-5-(1H-pyrrol-2- yl)-2H-pyrrol-2-ylidene]-
- 21038-14-2/7-Chloro-3,4-dihydro-3-methyl-1H-2,3-benzoxazine
- 82620-00-6/(6Z)-6-{5-[(2,6-dimethylpiperidin-1-yl)amino]-4-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-ylidene}cyclohexa-2,4-dien-1-one
- 143306-00-7/W 66
- 16707-41-8/N-[4-(2-BENZOXAZOLYL)PHENYL]MALEIMIDE
- 72990-30-8/(1Z)-1-pyridin-4-ylethanone O-prop-2-en-1-yloxime (2E)-but-2-enedioate
- 53028-44-7/2-(4-chloro-2-methylphenoxy)propanoic acid - 3-(3-chloro-4-methylphenyl)-1,1-dimethylurea (1:1)